U.S. limits use of J&J’s COVID vaccine on blood clot risks https://t.co/xMB8IqBoWp pic.twitter.com/h4rYBuajs0
— CTV News (@CTVNews) May 6, 2022
This morning.
Via CTV:
Cases of Thrombosis with thrombocytopenia syndrome (TTS), which involves blood clots accompanied by a low level of platelets, have previously been reported in recipients of the J&J vaccine.
The FDA in January amended the fact sheet for the J&J vaccine to include the risk of immune thrombocytopenia, months after the European Union’s drugs regulator took similar action.
The FDA on Thursday said the risk of TTS warranted limiting the use of the single-dose shot after it conducted investigation of reported cases.
U.S. limits use of J&J’s COVID vaccine on blood clot risks
RollingNews